Trials of inhaled Iloprost and other new vasodilating prostaglandins

被引:9
作者
Higenbottam, T [1 ]
Siddons, T [1 ]
机构
[1] Univ Sheffield, Sch Med, Div Clin Sci, Sheffield S10 2RX, S Yorkshire, England
关键词
D O I
10.1183/09031936.01.17100060
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:6 / 7
页数:2
相关论文
共 10 条
[1]   Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].
Badesch, DB ;
Tapson, VF ;
McGoon, MD ;
Brundage, BH ;
Rubin, LJ ;
Wigley, FM ;
Rich, S ;
Barst, RJ ;
Barrett, PS ;
Kral, KM ;
Jöbsis, MM ;
Loyd, JE ;
Murali, S ;
Frost, A ;
Girgis, R ;
Bourge, RC ;
Ralph, DD ;
Elliott, CG ;
Hill, NS ;
Langleben, D ;
Schilz, RJ ;
McLaughlin, VV ;
Robbins, IM ;
Groves, BM ;
Shapiro, S ;
Medsger, TA ;
Gaine, SP ;
Horn, E ;
Decker, JC ;
Knobil, K .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+
[2]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[3]  
FLENLEY DC, 1981, LANCET, V1, P681
[4]   PRIMARY PULMONARY-HYPERTENSION - NATURAL-HISTORY AND THE IMPORTANCE OF THROMBOSIS [J].
FUSTER, V ;
STEELE, PM ;
EDWARDS, WD ;
GERSH, BJ ;
MCGOON, MD ;
FRYE, RL .
CIRCULATION, 1984, 70 (04) :580-587
[5]  
HIGENBOTTAM T, 1984, LANCET, V1, P1046
[6]   Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. [J].
Hoeper, MM ;
Schwarze, M ;
Ehlerding, S ;
Adler-Schuermeyer, A ;
Spiekerkoetter, E ;
Niedermeyer, J ;
Hamm, M ;
Fabel, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1866-1870
[7]  
JONES DK, 1987, BRIT HEART J, V57, P270
[8]   Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension [J].
Nagaya, N ;
Uematsu, M ;
Okano, Y ;
Satoh, T ;
Kyotani, S ;
Sakamaki, F ;
Nakanishi, N ;
Miyatake, K ;
Kunieda, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) :1188-1192
[9]   Inhaled iloprost to treat severe pulmonary hypertension -: An uncontrolled trial [J].
Olschewski, H ;
Ghofrani, HA ;
Schmehl, T ;
Winkler, J ;
Wilkens, H ;
Höper, MM ;
Behr, J ;
Kleber, FX ;
Seeger, W .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :435-+
[10]  
Rich S, 1998, EXECUTIVE SUMMARY WO